Compositions and capsules with stable hydrophilic layers

• US 20070134493A1
• Filed: 12/08/2005
• Published: 06/14/2007
• Est. Priority Date: 12/08/2005
• Status: Abandoned Application

• Current Assignee: McNeil-PPC Incorporated (Johnson & Johnson)
• Original Assignee: McNeil-PPC Incorporated (Johnson & Johnson)
• Inventors: Meghpara, Kanji
• Application Number:
  US11/296,989
• Publication Number:
  US 20070134493A1
• Time in Patent Office: Days
• US Class Current: 428/402.200
• CPC Class Codes: A61J 3/07 into the form of capsules or similar small containers for oral use
• CPC Class Codes: A61K 9/0056 Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
• CPC Class Codes: A61K 9/4891 Coated capsules; Multilayered drug free capsule shells with drug coating for immediate release A61K9/4808; osmotic devices A61K9/0004
• CPC Class Codes: Y10T 428/2984 Microcapsule with fluid core [includes liposome]

Abstract

Several embodiments of the present invention provide a capsule including a hydrophobic inner core layer and at least one hydrophilic outer layer. The outer layer may be seamless and may include at least one hygroscopic polyol and at least one polyol with a low hygroscopicity. The at least one outer layer may include at least one film or gel forming agent. Such capsules are stable and experience minimal or no degradation under accelerated stability conditions.

Claims

1. A capsule comprising a hydrophobic inner core and at least one hydrophilic outer layer;

said outer layer comprises at least one hygroscopic polyol and at least one polyol with a low hygroscopicity.

2. The capsule according to claim 1, wherein said at least one hydrophilic outer layer further comprises at least one film or gel forming agent.

3. The capsule of claim 1, said polyol with a low hygroscopicity comprises isomalt.

4. The capsule of claim 1, said hygroscopic polyol is selected from the group consisting of glycerin, sorbitol, mannitol, xylitol, maltitol, lactitol, erythritol and the like and combinations thereof.

5. The capsule according to claim 2, wherein said at least one film or gel forming agent is selected from the group consisting of gelatin, pullulan, hydroxypropylmethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, polyvinyl pyrrolidone, carboxymethyl cellulose, polyvinyl alcohol, sodium alginate, polyethylene glycol, tragacanth gum, guar gum, acacia gum, arabic gum, polyacrylic acid, methylmethacrylate copolymers, carboxyvinyl polymers, amylose, high amylose starch, hydroxypropylated high amylose starch, dextrin, chitin, chitosan, levan, elsinan, collagen, zein, gluten, soy protein isolate, whey protein isolate, casein and combinations thereof.

6. The capsule of claim 1, said hydrophobic inner core comprises at least one active pharmaceutical ingredient in a pharmaceutically effective amount.

7. The capsule of claim 1, wherein said capsule further comprises at least one additional layer located between the inner core and the hydrophilic outer layer.

8. The capsule of claim 1, wherein said capsule is a standalone product that is capable of disintegrating completely in an oral cavity of a consumer.

9. The capsule of claim 8, wherein said capsule disintegrates in an oral cavity in less than about 20 seconds and does not leave a gelatin residue in the oral cavity.

10. The capsule of claim 1, wherein said capsule has a seamless outer layer.

11. The capsule of claim 1, wherein said capsule is stable and said at least one outer layer experiences minimal degradation at accelerated stability conditions at 30°

C./65% relative humidity.

12. The capsule according to claim 1, wherein said capsule has a diameter from about 0.1 mm to about 10 mm.

13. The capsule according to claim 1 wherein said at least one hygroscopic polyol is present in an amount from about 1% to about 50% by weight.

14. The capsule according to claim 1 wherein said at least one hygroscopic polyol is present in an amount from about 10% to about 30% by weight.

15. The capsule according to claim 1 wherein said at least one polyol with a low hygroscopicity is present in an amount from about 1% to about 50% by weight.

16. The capsule according to claim 1 wherein said at least one polyol with a low hygroscopicity is present in an amount from about 10% to about 40% by weight.

17. The capsule according to claim 6, wherein said active pharmaceutical ingredient is encapsulated or partially encapsulated with an acrylic copolymer.

18. The capsule according to claim 6, wherein said active pharmaceutical ingredient is selected from the group consisting of diphenhydramine, dextromethorphan, menthol, phenylephrine, pseudoephedrine, acetaminophen, ibuprofen, famotidine, guaifenesin, ketoprofen, nicotine, celecoxib, valdecoxib, chlorpheniramine, fexofenadine, loratadine, desloratadine, cetirizine, ranitidine, simethicone, and isomers, pharmaceutically acceptable salts and prodrugs thereof and combinations thereof.

19. A capsule comprising a hydrophobic inner core and at least one hydrophilic outer layer;

said outer layer comprises at least one film or gel forming agent, at least one hygroscopic polyol and at least one polyol with a low hygroscopicity;

said hydrophobic inner core comprises at least one active pharmaceutical ingredient in a pharmaceutically effective amount and said at least one outer layer experiences minimal degradation at 30°

C./65% relative humidity.

20. A package comprising a capsule comprising a hydrophobic inner core and at least one hydrophilic outer layer;

said outer layer comprises at least one hygroscopic polyol and at least one polyol with a low hygroscopicity;

said package comprises drug facts attached thereto.